• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

SteadyMed sets terms for $55m IPO

March 10, 2015 By Brad Perriello

SteadyMed sets terms for $55m IPO

SteadyMed Therapeutics yesterday set the terms for its pending debut on the public market, saying it plans to float 4.25 million shares at $12 to $14 apiece.

At the midpoint that would bring in $55.2 million for SteadyMed, which has operations in Israel and California. The company makes hypertension and pain treatments delivered with a discrete, patented drug-delivery device.

SteadyMed, which according to a regulatory filing plans to trade on the NASDAQ exchange under the symbol "STDY," is focused on winning U.S. approval for Treyvent, a drug to treat pulmonary arterial hypertension. The specialty pharmaceutical company also said it has 2 drugs under development to treat post-surgery pain at home.

The company also developed the PatchPump technology, a discrete, water-resistant and disposable pre-filled drug-delivery device. PatchPump devices are designed to be "pre-programmed to deliver an accurate, steady flow of drug to a patient, either subcutaneously or intravenously," according to SteadyMed’s IPO prospectus.

SteadyMed said in its IPO filing that it hopes to license the technology to pharmaceutical and biopharmaceutical companies for use with larger-volume, high-value, small-molecule or biologic drugs. The company launched in Israel in 2005.

Filed Under: Drug-Device Combinations Tagged With: SteadyMed Therapeutics

IN CASE YOU MISSED IT

  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS